Mathias Viard Selected Research

CCR5 Receptors (CCR5 Receptor)

1/2019

CCR5AS lncRNA variation differentially regulates CCR5, influencing HIV disease outcome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mathias Viard Research Topics

Disease

6	Breast Neoplasms (Breast Cancer) 01/2020 - 01/2015
5	Neoplasms (Cancer) 01/2022 - 03/2013
5	Infections 11/2021 - 01/2004
2	Melanoma (Melanoma, Malignant) 11/2018 - 01/2004
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2022
1	Parasitemia 01/2021
1	Communicable Diseases (Infectious Diseases) 01/2021
1	Acquired Immunodeficiency Syndrome (AIDS) 11/2020
1	Aplastic Anemia (Anemia, Hypoplastic) 01/2020
1	Esophageal Neoplasms (Esophageal Cancer) 05/2019
1	HIV Infections (HIV Infection) 01/2019
1	Disease Progression 01/2019
1	Prostatic Neoplasms (Prostate Cancer) 10/2016
1	Human Influenza (Influenza) 03/2012
1	Virus Diseases (Viral Diseases) 05/2008

Drug/Important Bio-Agent (IBA)

4	Small Interfering RNA (siRNA)IBA 06/2020 - 01/2015
3	RNA (Ribonucleic Acid)IBA 11/2018 - 03/2016
3	LipidsIBA 10/2018 - 01/2015
2	Peptides (Polypeptides)IBA 11/2020 - 11/2012
2	VaccinesIBA 03/2012 - 05/2008
2	Glycoproteins (Glycoprotein)IBA 12/2005 - 01/2004
2	GlycosphingolipidsIBA 01/2004 - 01/2004
1	Axitinib (AG 013736)IBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	avelumabIBA 01/2022
1	NivolumabIBA 01/2022
1	Sunitinib (Sutent)FDA Link 01/2022
1	Everolimus FDA Link 01/2022
1	HLA-A Antigens (HLA-A)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 11/2021
1	HLA-C Antigens (HLA-C)IBA 01/2021
1	LigandsIBA 01/2021
1	KIR ReceptorsIBA 01/2021
1	tapasinIBA 11/2020
1	bolaamphiphileIBA 06/2020
1	PolymersIBA 01/2020
1	HLA-DPB1 antigen (HLA DPB1)IBA 01/2020
1	chlorinIBA 05/2019
1	pyropheophorbide aIBA 05/2019
1	2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a (HPPH)IBA 05/2019
1	Photosensitizing Agents (Photosensitizers)IBA 05/2019
1	CCR5 Receptors (CCR5 Receptor)IBA 01/2019
1	Long Noncoding RNAIBA 01/2019
1	NucleotidesIBA 11/2018
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 10/2018
1	OximesIBA 01/2015
1	Ether (Diethyl Ether)IBA 01/2015
1	Hydroxyl RadicalIBA 01/2015
1	Antiviral Agents (Antivirals)IBA 11/2012
1	safingol (sphinganine)IBA 11/2012
1	Detergents (Detergent)IBA 03/2012
1	Neuraminidase (Sialidase)IBA 05/2008

Therapy/Procedure

2	Therapeutics 01/2022 - 03/2013
1	Aftercare (After-Treatment) 01/2022
1	Drug Therapy (Chemotherapy) 10/2018